Bültmann & Gerriets
Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems
von Kevin L. Williams
Verlag: Springer International Publishing
Gebundene Ausgabe
ISBN: 978-3-030-17147-6
Auflage: 1st ed. 2019
Erschienen am 07.08.2019
Sprache: Englisch
Format: 241 mm [H] x 160 mm [B] x 53 mm [T]
Gewicht: 1472 Gramm
Umfang: 884 Seiten

Preis: 235,39 €
keine Versandkosten (Inland)


Jetzt bestellen und voraussichtlich ab dem 14. Oktober in der Buchhandlung abholen.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

235,39 €
merken
zum E-Book (PDF) 160,49 €
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Biografische Anmerkung
Inhaltsverzeichnis

Endotoxin detection and control is a dynamic area of applied science that touches a vast number of complex subjects. The intersection of test activities includes the use of an ancient blood system from an odd ¿living fossil¿ (Limulus). It is used to detect remnants of the most primitive and destructive forms of life (prokaryotes) as contaminants of complex modern systems (mammalian and Pharma).
Recent challenges in the field include those associated with the application of traditional methods to new types of molecules and manufacturing processes. The advent of ¿at will¿ production of biologics in lieu of harvesting animal proteins has revolutionized the treatment of disease. While the fruits of the biotechnology revolution are widely acknowledged, the realization of the differences in the means of production and changes in the manner of control of potential impurities and contaminants in regard to the new versus the old are less widely appreciated.
Endotoxin as an ancient, dynamic interface between lifeforms, provides a singular perspective from which to view the parallel development of ancient and modern organisms as well as the progress of man in deciphering the complexity of their interactions in his efforts to overcome disease.



Kevin Williams graduated from Texas A&M in 1982 with a BS in Microbiology. From there spent 30 years at Eli Lilly in Indianapolis. After retirement he has been at Hospira, Lonza, GE, and now BioMerieux .



Introduction.- Section I Pharma.- Historical Perspectives.- Risk, Control and Compliance..- Sterility and Beyond.- LVPs and SMDs.- Specification Determination.- Static and Dynamic Models (Biodiversity and Heterogeneity) .- Test Development and Validation.- Diminishing Analytics.- Control in Biologics Manufacture.- Depyrogenation and Medical Devices.- Nanoparticles / Problematic Drug Types.- New Frontiers.- Section II Limulus.- Evolution, a Living Fossil and Other Model Arthropods.- Water, Water Everywhere.- Survival and Mass Extinction Events.- Limulus Soup / Hemolymph.- Is Innate Modeling Enough?.- A Foreboding.- Section III Mammalian.- Innate is Inborn.- The Host Response: Fever and Inflammation.- . Parallel Immune Systems: Architecture and Mechanisms.- Structural Change is Functional Change (Hand in Glove).- Endotoxin and Adjuvanticity in Vaccinology.- Advancesin Diagnostics.- The Big S.


andere Formate